£74.40

Springer Human Growth Hormone

Price data checked 1 day ago

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£74 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 90 days • 90 data points

Historical
Generating forecast...
£74.40 £70.68 £72.17 £73.66 £75.14 £76.63 £78.12 18 February 2026 12 March 2026 03 April 2026 25 April 2026 18 May 2026

Price Distribution

Price distribution over 90 days • 1 price levels

Days at Price
90 days 0 23 45 68 90 £74 Days at Price

Price Analysis

Most common price: £74 (90 days, 100.0%)

Price range: £74 - £74

Price levels: 1 different prices over 90 days

Description

It has been ten years since the National Hormone and Pituitary Program (then called the National Pituitary Agency) sponsored a symposium on human growth hormone (hGH). Numerous advances have occurred during this period. This book does not attempt to summarize past achievements. Rather, it deals with the contemporary issues in hGH research. A discussion of the present state of the art, of necessity, includes a review of the past. Some of the topics herein discussed include the following: 1. Growth hormone releasing factor (GRF). In 1973, the growth hormone inhibitory factor (somatostatin) had recently been discovered. The search for a releasing factor in humans led to its discovery not in the pituitary but in a pancreatic tumor that secreted growth hormone. The advances are discussed in this book. The current hope is that GRF will eventually become an effective therapeutic agent for idiopathic hypopituitarism in childhood and adolescence. 2. Biosynthesis of hGR by recombinant DNA technology. Current advances are discussed. Although hGH is not yet an approved drug, it will eventually become one. This will broaden our horizons in terms of hGH effectiveness in disorders other than hypopituitary dwarfism. The current experience with this type of hGH in both the Vnited States and Europe is reviewed by several authors.

Product Specifications

Format
paperback
Domain
Amazon UK
Publication Date
27 May 2013
Listed Since
07 November 2013

Barcode

No barcode data available

Similar Products You Might Like

GHRH, GH, and IGF-I: Basic and Clinical Advances (Serono Symposia USA)
86% match

GHRH, GH, and IGF-I: Basic and Clinical Advances (Serono Symposia USA)

Springer

£146.00 04 May 2026
Central Regulation of Growth: Morphological & Functional Considerations
85% match

Central Regulation of Growth: Morphological & Functional Considerations

£142.49 18 May 2026
Deciphering Growth (Research and Perspectives in Endocrine Interactions)
85% match

Deciphering Growth (Research and Perspectives in Endocrine Interactions)

Springer

£113.76 18 May 2026
Growth Hormone And The Heart: 9 (Endocrine Updates, 9)
83% match

Growth Hormone And The Heart: 9 (Endocrine Updates, 9)

Springer

£113.76 18 May 2026
Sex-steroid Interactions with Growth Hormone (Serono Symposia)
82% match

Sex-steroid Interactions with Growth Hormone (Serono Symposia)

Springer

£111.50 04 May 2026
Diseases of the Pituitary: Diagnosis and Treatment: 3 (Contemporary Endocrinology, 3)
81% match

Diseases of the Pituitary: Diagnosis and Treatment: 3 (Contemporary Endocrinology, 3)

Humana

£84.86 04 May 2026
GnRH: The Master Molecule of Reproduction
80% match

GnRH: The Master Molecule of Reproduction

Springer

£142.61 18 May 2026
Peptides and Non Peptides of Oncologic and Neuroendocrine Relevance: From Basic to Clinical Research
80% match

Peptides and Non Peptides of Oncologic and Neuroendocrine Relevance: From Basic to Clinical Research

Springer

£113.76 18 May 2026
Diseases of the Pituitary: Diagnosis and Treatment: 3 (Contemporary Endocrinology, 3)
80% match

Diseases of the Pituitary: Diagnosis and Treatment: 3 (Contemporary Endocrinology, 3)

Humana

£84.65 18 May 2026
Insulin-like Growth Factors and Cancer: From Basic Biology to Therapeutics (Cancer Drug Discovery and Development)
79% match

Insulin-like Growth Factors and Cancer: From Basic Biology to Therapeutics (Cancer Drug Discovery and Development)

Humana

£107.57 18 May 2026
Management of Pituitary Tumors: The Clinician’s Practical Guide
79% match

Management of Pituitary Tumors: The Clinician’s Practical Guide

Humana

£80.64 18 May 2026
Structure and Function of the Gonadotropins (Biochemical Endocrinology)
79% match

Structure and Function of the Gonadotropins (Biochemical Endocrinology)

Springer

£77.33 18 May 2026
Biology of Growth Factors: Molecular Biology, Oncogenes, Signal Transduction, and Clinical Implications: 234 (Advances in Experimental Medicine and Biology, 234)
78% match

Biology of Growth Factors: Molecular Biology, Oncogenes, Signal Transduction, and Clinical Implications: 234 (Advances in Experimental Medicine and Biology, 234)

Springer

£76.38 18 May 2026
Recombinant DNA Products: Insulin, Interferon and Growth Hormone
78% match

Recombinant DNA Products: Insulin, Interferon and Growth Hormone

CRC Press

£90.36 11 May 2026
Diagnosis and Management of Pituitary Tumors
78% match

Diagnosis and Management of Pituitary Tumors

Humana

£110.18 18 May 2026
Endocrine Disruptors and Puberty (Contemporary Endocrinology)
78% match

Endocrine Disruptors and Puberty (Contemporary Endocrinology)

Humana

£107.85 04 May 2026
Acromegaly: Pathology, Diagnosis and Treatment
77% match

Acromegaly: Pathology, Diagnosis and Treatment

CRC Press

£61.44 11 May 2026
Neurotrophic Factors: 25 (Neuromethods, 25)
77% match

Neurotrophic Factors: 25 (Neuromethods, 25)

Humana

£107.98 18 May 2026
Cushing’s Syndrome
77% match

Cushing’s Syndrome

Springer

£113.94 18 May 2026
Pituitary Disorders: Diagnosis and Management
77% match

Pituitary Disorders: Diagnosis and Management

Wiley-Blackwell

£102.95 04 May 2026
Functional Anatomy of the Neuroendocrine Hypothalamus: No. 168 (Novartis Foundation Symposia)
76% match

Functional Anatomy of the Neuroendocrine Hypothalamus: No. 168 (Novartis Foundation Symposia)

Wiley-Blackwell

£90.00 15 May 2026
TGF-β in Human Disease
76% match

TGF-β in Human Disease

Springer

£113.49 11 May 2026
Textbook of Energy Balance, Neuropeptide Hormones, and Neuroendocrine Function
76% match

Textbook of Energy Balance, Neuropeptide Hormones, and Neuroendocrine Function

Springer

£65.57 11 May 2026
Male Hypogonadism: Basic, Clinical, and Therapeutic Principles (Contemporary Endocrinology)
76% match

Male Hypogonadism: Basic, Clinical, and Therapeutic Principles (Contemporary Endocrinology)

Humana

£73.10 18 May 2026